PICI Network Researchers Featured at AACR Pancreatic Cancer Conference #AACRpan22

Parker Institute for Cancer Immunotherapy (PICI) Network investigators will discuss the latest findings in pancreatic cancer research at the 8th AACR Special Conference on Pancreatic Cancer, Sept. 13-16 in Boston. Spanning basic, translational and clinical research, the conference highlights the advancements and diversity of the field. 

Parker Institute member Robert H. Vonderheide, MD, DPhil, of the University of Pennsylvania is one of four conference co-chairs.

Avery D. Posey, PhD (Twitter: @IAmDrDex), of the University of Pennsylvania will deliver the Rising Star Keynote address, “Truncated O-glycosylation in pancreatic cancer,” Sept. 13 between 6 and 7:25 p.m. Eastern time.

Below are other select sessions featuring Parker Institute investigators.

Plenary Session 2: Bench to Bedside: The Science That Underpins Clinical Trials
Sept. 14, 10:30 a.m.-12:30 p.m. Eastern

Presenter: Dr. Vonderheide
Topic: Were the Mice Right? Applying Immunobiological Insights from the Lab to the Treatment of Patients with Pancreatic Cancer

Plenary Session 3: Tumor Plasticity and Drug Resistance
Sept. 14, 2-4 p.m. Eastern

Presenter: Scott W. Lowe, PhD (Twitter: @LoweLabMSKCC) of Memorial Sloan Kettering Cancer Center
Topic: The Origins and Function of Copy Number Alterations in Pancreas Cancer

Debate: Targeting the Tumor vs. Stroma
Sept. 16, 12:15-1 p.m. Eastern

Moderator: Eileen O’Reilly, MD (Twitter: @EileenMOReilly), of Memorial Sloan Kettering Cancer Center

Additionally, Dr. Vonderheide will host a breakfast roundtable, “How to Get a Paper Published, Sept. 14 from 7-8 a.m. Eastern. Dr. O’Reilly will host a breakfast roundtable, “Collaborating with Industry,” Sept. 15 from 7-8 a.m. Eastern.

Please note that all events listed are subject to change. For the most up-to-date information, visit the event program. Follow the meeting live on Twitter using the hashtag #AACRpan22.